Abstract
The pharmacological activities of δ9-THC [(−)-δ9-trans-tetrahydrocannabinol], CBN (Cannabinol) and mixtures of δ9-THC + CBN were studied in rabbits, rats and mice.
CBN, although in general less active, mimicked the effects of δ9-THC in several pharmacological tests: corneal arreflexia in rabbits; climbing rope, open-field, irritability and aggressiveness after REM sleep deprivation in rats; catatonia, analgesia and sleeping time in mice.
When the mixture δ9-THC + CBN was used, a synergistic effect occurred on most of the depressant effects. On the other hand CBN did not interfere with or slightly inhibited the excitatory effects of δ9-THC. In the one peripheral test used, CBN did not alter the δ9-THC effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alves, C. N., Goyos, A. C., Carlini, E. A.: Aggressiveness induced by marihuana and other psychotropic drugs in REM sleep deprived rats. Pharmacol. Biochem. Behav. 1, 183–189 (1973)
Borgen, L. A., Lott, G. C., Davis, W. M.: Cannabis induced hypothermia: a dose effect comparison of crude marihuana extract and synthetic δ9-tetrahydrocannabinol in male and female rats. Res. Com. Chem. Path. Pharmacol. 5, 621–627 (1973)
Carlini, E. A., Masur, J.: Development of aggressive behavior in rats by chronic administration of Cannabis sativa (marihuana). Life Sci. 8 (part 1), 607–620 (1969)
Carlini, E. A., Masur, J., Karniol, I. G., Leite, J. R.: II. Cannabis sativa: Is it possible to consider behavioral animal data as experimental models for some effects on humans? In: Cannabis and its derivatives, pharmacology and experimental psychology. Paton, W. D. M. and Crown, J., eds., pp. 154–175. London: Oxford University Press 1972
Carlini, E. A., Karniol, I. G., Renault, P. F., Schuster, C. R.: Marihuana effects in laboratory animals and in human beings. Brit. J. Pharmacol. 50, 299–310 (1974)
Eddy, N. B., Leimbach, D.: Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J. Pharmacol. exp. Ther. 107, 385–393 (1953)
Fernandes, M., Coper, H.: The role of vehicles in cannabis application and interaction between cannabis and central active drugs. Acta pharm. suecica 8, 692–693 (1971)
Frankenheim, J. M., McMillan, D. E., Harris, L. S.: Effects of δ9- and δ8-trans-tetrahydrocannabinol and cannabinol on schedule-controlled behavior of pigeons and rats. J. Pharmacol. exp. Ther. 178, 241–253 (1971)
Grisham, M. G., Ferraro, D. P.: Biphasic effects of δ9-tetrahydrocannabinol on variable interval schedule performance in rats. Psychopharmacologia (Berl.) 27, 163–170 (1972)
Hollister, L. E.: Marihuana in man: three years later. Science 172, 21–28 (1971)
Karniol, I. G., Carlini, E. A.: The content of (−) δ9-transtetrahydrocannabinol does not explain all biological activity of some brazilian marihuana samples. J. Pharm. Pharmacol. 24, 833–835 (1972)
Karniol, I. G., Carlini, E. A.: Pharmacological interaction between cannabidiol and δ9-tetrahydrocannabinol. Psychopharmacologia (Berl.) 33, 53–70 (1973)
Karniol, I. G., Shirakawa, I., Kasinski, N., Pfefferman, A., Carlini, E. A.: Cannabidiol interferes with the effects of δ9-tetrahydrocannabinol in man. Europ. J. Pharmacol., submitted to publication
Krantz, J. C., Berger, H. J., Welch, B. L.: Blockade of (−)-trans-δ9-tetrahydrocannabinol depressant effect by cannabinol in mice. Amer. J. Pharmacol. 143, 149–152 (1971)
Lapa, A. J., Sampaio, C. A. M., Timo-Iaria, C., Valle, J. R.: Blocking action of tetrahydrocannabinol upon transmission in the trigeminal system of the cat. J. Pharm. Pharmacol. 20, 373–376 (1968)
Loewe, S.: Marihuana activity of cannabinol. Science 102, 615–616 (1945)
Masur, J.: Sex differences in “emotionality” and behavior of rats in the open-field. Behav. Biol. 7, 749–754 (1972)
Masur, J., Martz, R. M. W., Carlini, E. A.: Effects of acute and chronic administration of Cannabis sativa and (−)-δ9-trans-tetrahydrocannabinol on the behavior of rats in an open-field arena. Psychopharmacologia (Berl.) 19, 388–397 (1971)
Mechoulam, R., Ben-Zvi, Z., Shani, A., Zemler, H., Levy, S., Edery, H., Grunfeld, Y.: Cannabinoids and Cannabis activity. In: Cannabis and its derivatives-pharmacology and experimental psychology, Paton, W. D. M., and Crown, J., eds., pp. 1–15. London: Oxford University Press 1972
Nakamura, K., Thoenen, H.: Increased irritability: a permanent behavior change induced in the rat by the intraventricular administration of 6-hydroxytryptamine. Psychopharmacologia (Berl.) 24, 359–372 (1972)
Poddar, M. K., Ghosh, J. J.: Effect of cannabis extract, δ9-tetrahydrocannabinol and lysergic acid diethylamide on rat liver enzymes. Biochem. Pharmacol. 21, 3301–3303 (1972)
Potvin, R. J., Fried, P. A.: Acute and chronic effects on rats of (−)-δ1-trans-tetrahydrocannabinol on unlearned motor tasks. Psychopharmacologia (Berl.) 26, 369–378 (1972)
Sofia, R. D., Kubena, R. K., Barry, H., III: Comparison of four vehicles for intraperitoneal administration of δ1-tetrahydrocannabinol. J. Pharm. Pharmacol. 23, 889–891 (1971)
Willinsky, M. D., Scotti, A. C., Longo, V. G.: EEG and behavioral effects of natural synthetic and biosynthetic cannabinoids. Psychopharmacologia (Berl.) 31, 365–374 (1973)
Author information
Authors and Affiliations
Additional information
With a fellowship from FundaÇÃo de Amparo a Pesquisa do Estado de S. Paulo.
Rights and permissions
About this article
Cite this article
Takahashi, R.N., Karniol, I.G. Pharmacological interaction between cannabinol and δ9-tetrahydrocannabinol. Psychopharmacologia 41, 277–284 (1975). https://doi.org/10.1007/BF00428937
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00428937